Sickle cell disease trials in Brunei

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Study of the Role of Genetic Modifiers in Hemoglobinopathies

  Where

  Brunei

  Age

  2 years and over

  People

  30,000 worldwide

  Run by

  Cyprus Institute of Neurology and Genetics

  See details and how to joinNCT05799118